AstraZeneca
Prescription Drugs · Oncology Therapeutics

AstraZeneca: Risk & public record

AstraZeneca: an SBTi-validated climate target, 6,522 research papers in five years, 3 competition cases, $680k of EU lobbying in 2025, 519 federal court cases.

Data updated Nov 21, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
Not checked
Postings are real
Alion truth index: A
89/100
Ghost roles
re-checked against its careers site
6%
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Domain in use
astrazeneca.com: first seen in registries and web archives · lookup.icann.org ↗
since 2018
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Domain and mail securityastrazeneca.com · Nov 14, 2026
Spoofed mail (DMARC)
Monitors only (p=none) · dns.google ↗
Weak
Who may send its mail (SPF)
Other senders soft-fail (~all) · dns.google ↗
Weak
HTTPS certificate
Valid certificate · Sectigo Limited · crt.sh ↗
Good
HTTPS enforced (HSTS)
Not enforced · hstspreload.org ↗
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy · dns.google ↗
Weak
Signed DNS (DNSSEC)
Not signed · dnsviz.net ↗
Weak
Certificate issuers (CAA)
Any authority may issue certificates · dns.google ↗
Weak
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.

Public record

AstraZeneca: an SBTi-validated climate target, 6,522 research papers in five years, 3 competition cases, $680k of EU lobbying in 2025, 519 federal court cases.

Research outputpapers its people wrote, per OpenAlex
6,522papers in five years
963kcitations
Asthma and respiratory diseases
Medicine
1,424 papers
Lung Cancer Treatments and Mutations
Medicine
1,328 papers
Chronic Obstructive Pulmonary Disease (COPD) Research
Medicine
1,235 papers
Computational Drug Discovery Methods
Pharmacology, Toxicology and Pharmaceutics
1,034 papers
Cancer Immunotherapy and Biomarkers
Medicine
947 papers

Works most with: University of London, University of Cambridge, Istituti di Ricovero e Cura a Carattere Scientifico, Mass General Brigham, Harvard University, Memorial Sloan Kettering Cancer Center

Employer reportswhat UK and French law makes employers publish
Modern slavery statement (UK), 2026
turnover Over £500 million
Competition casesthe European Commission's merger, antitrust and cartel cases and the UK CMA's cases naming it
ASTRAZENECA / ALEXION PHARMACEUTICALS
European Commission M.10165 · merger · Art. 6(1)(b) · cleared · Normal · Jul 2021
AstraZeneca / Alexion Pharmaceuticals merger inquiry
UK CMA · mergers · mergers phase 1 clearance · closed · Jun 2021
BMS / ASTRAZENECA / AMYLIN BUSINESS
European Commission M.6708 · merger · Art. 6(1)(b) · cleared · Simplified · Mar 2013
Stock exchange announcementsfiled with the FCA's National Storage Mechanism: results, deals, board changes, share issues
Admission of Further Securities to Trading
Admission to Trading
Nov 2
3rd Quarter Results
3rd Quarter Results
Oct 30
Admission of Further Securities to Trading
Admission to Trading
Oct 1
Admission of Further Securities to Trading
Admission to Trading
Sep 1
Admission to Trading - €2.55 billion bond offering
Admission to Trading
Sep 1
Directorate change
Directorate change
Sep 1
ClimateSBTi targets, US EPA and EU ETS emissions

SBTi-validated near-term target: 1.5°C

Influence
US lobbying
2025 · Tiber Creek Group $360,000, Tarplin, Downs & Young, LLC $320,000 · disclosurespreview.house.gov ↗
$680k
EU lobbying, declared
2025 · Kreab Worldwide, Edelman Public Relations Worldwide, FTI Consulting Belgium, APCO Worldwide, CONCILIUS AG · transparency-register.europa.eu ↗
EUR 800,000–899,999
Employees' political contributions, 2026 cycle
466 contributions · their own money, not the company's; names not shown · fec.gov ↗
$82k
Patents
Published US applications
5
US federal cases naming it as a party
Nov 2022 – Jan 2026 · 519 as defendant · 192 closed
Most common: 367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability 13, 410 Anti-Trust 1, Other Statutes: Racketeer/Corrupt Organization 1, 850 Securities/Commodities 1
519
The case list: courts, dates and the other sidePremiumUnlockor this company alone for 30 days · 50 credits
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.